参考文献/References:
[1] 许敬人, 张春燕, 茅惠明,等. 补肾通督方对强直性脊柱炎患者血清TNF-α、TGF-β1及骨代谢的影响[J]. 上海中医药大学学报, 2008, 22(1):33-35.
[2] Perpetuo IP, Caetano-Lopes J, Vieira-Sousa E, et al. Corrigendum: ankylosing spondylitis patients have impaired osteoclast gene expression in circulating osteoclast precursors[J]. Frontiers Med, 2017, 4(10):38-39.
[3] 蔡余力, 张兴彩, 张厚君,等. 补肾通阳法调节强直性脊柱炎患者TNF-α和TGF-β1的研究[J]. 中医药学报, 2017, 45(3):70-73.
[4] 朱元悦, 张 玲, 孙 柔, 等. 强直性脊柱炎患者外周血T细胞亚群及相关免疫分子的变化[J]. 现代免疫学, 2017, 34(1):14-19.
[5] Fan J, Zhao J, Shao J, et al. I-BET151 inhibits expression of RANKL, OPG, MMP3 and MMP9 in ankylosing spondylitis in vivo and in vitro[J]. ExpTherap Med, 2017, 14(5):4602-4606.
[6] 张 征, 孙其桓, 白 晶,等. 活动性强直性脊柱炎患者外周血MIF、IL-23、RANKL、OPG和DKK1检测的临床意义[J]. 河北医药, 2018, 40(2):178-182.
[7] Hu Z, Lin D, Qi J, et al. Serum from patients with ankylosing spondylitis can increase PPARD, fra-1, MMP7, OPG and RANKL expression in MG63 cells[J]. Clinics, 2015, 70(11):738-742.
[8] 周绮红. 鹿瓜多肽中骨诱导多肽类生物因子在临床中应用[J].中国伤残医学, 2017, 25(18):100-101.
[9] 李晓丽, 刘玲玲, 赵 龙, 等. 2型糖尿病患者血浆TGF-β 1 水平及其与心脏结构和功能的关系[J]. 江苏大学学报: 医学版, 2015, 34(4): 317-321.
[10] 高 巍, 武 忠, 李敏州, 等. 中医药基于TGF-β1治疗糖尿病肾病研究概况[J]. 中医药临床杂志, 2017, 29(2): 164-167.
[11] Layhschmitt G, Lu S, Navid F, et al. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors[J]. Clin Rheumatol, 2017, 36(1):143-154.
[12] Mou YK, Zhang PP, Li QX, et al. Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes[J]. Clinical Rheumatology, 2015, 34(6):1085-1089.
[13] Luo H. Serum OPG and sRANKL in evaluating the disease activity of ankylosing spondylitis[J]. Acta Universitatis Medicinalis Nanjing, 2011, 31(10):1455-1458.
[14] Mcgarry F, Cousins L, Sturrock RD, et al. A polymorphism within the Transforming Growth Factor β1 gene is associated with ankylosing spondylitis (AS)[J]. Arthritis Research, 2002, 4(1):22-23.
[15] 邵景韫, 戚好文, 刘 安,等. 胸腔积液中TGF-β1、VEGF、bFGF、PAI-1的检测及其临床意义[J].陕西医学杂志, 2006, 35(1):100-101.
[16] 时代音,胡春婷,何 娅.黄芪汤对酒精性肝纤维化大鼠TNF-α及TGF-β1的影响[J]. 陕西中医, 2011, 32(6):758-759.
[17] 许敬人,张春燕,李伟民,等.补肾通督方对强直性脊柱炎血清TNF-α及TGF-β1水平的影响[J].中国中西医结合杂志, 2008, 28(12):1093-1095.
相似文献/References:
[1]戴 璐.柳氮磺胺吡啶联合益赛普治疗不同年龄强直性脊柱炎 临床效果及对患者生活质量的影响研究*[J].陕西医学杂志,2019,(2):262.
DAI Lu..Clinical effect of sulfasalazine combined with Yisaipu on ankylosing spondylitis in different age groups and its
impact on patients’ quality of life[J].,2019,(8):262.
[2]沈斯瑶,刘 艳△,徐鹏刚.白芍总苷联合沙利度胺治疗强直性脊柱炎疗效及对患者活动指标、血清炎性因子水平的影响*[J].陕西医学杂志,2020,49(1):20.
SHEN Siyao,LIU Yan,XU Penggang..Effect of total glucosides of paeony combined with thalidomide on activity indicators and serum inflammatory factors in the treatment of ankylosing spondylitis patients[J].,2020,49(8):20.
[3]牛 敏,杨西超,闫美茜,等.强直性脊柱炎患者肥胖与炎性指标、疾病严重程度指标和心血管疾患危险因素指标相关性分析[J].陕西医学杂志,2021,50(11):1383.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.015]
NIU Min,YANG Xichao,YAN Meixi,et al.Correlation between obesity and inflammatory indicators,disease severity indicators and cardiovascular disease risk factors in patients with ankylosing spondylitis[J].,2021,50(8):1383.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.015]